Wordt geladen...
Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia
Gilteritinib induces 2 distinct marrow responses in FLT3-mutated AML: responses with and without differentiation. Ongoing clonal hematopoiesis is ubiquitous during gilteritinib therapy and may promote genetic evolution and drug resistance.
Bewaard in:
| Gepubliceerd in: | Blood Adv |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society of Hematology
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6538870/ https://ncbi.nlm.nih.gov/pubmed/31122910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018029496 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|